Journals / İstanbul Kuzey Klinikleri / 2015 / Cilt: 2 - Sayı: 3

Treatment of chylothorax developed after congenital heart disease surgery: a case report

Pages
227–230
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A neonate who developed chylothorax after surgery performed for congenital heart disease was treated successfully with octreotide.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chylothorax is defined as the accumulation of lymphatic fluid or chyle in the pleural space.
📊
Key Findings & Data:Chylothorax treatment is composed of conservative; pleural drainage, termination of enteral feeding, total parenteral nutrition and supplementation with medium- chain triglycerides and surgical therapies; ductus thoracicus ligation, pleuroperitoneal shunts or pleuredesis.
💡
Conclusion & Impact:A neonate who developed chylothorax after surgery performed for congenital heart disease was treated successfully with octreotide.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Chylothorax is defined as the accumulation of lymphatic fluid or chyle in the pleural space. Chylothorax treatment is composed of conservative; pleural drainage, termination of enteral feeding, total parenteral nutrition and supplementation with medium- chain triglycerides and surgical therapies; ductus thoracicus ligation, pleuroperitoneal shunts or pleuredesis. Nowadays, for cases among which conservative therapies fail, treatment with octreotide has been reported to be beneficial with promising results. A neonate who developed chylothorax after surgery performed for congenital heart disease was treated successfully with octreotide.

🔖

Cite This Article

BUYUKKAYHAN, D., MUNGAN, I., SEVUK, S., BULUT, O., GUL, D. (2022). Treatment of chylothorax developed after congenital heart disease surgery: a case report. İstanbul Kuzey Klinikleri, Cilt: 2 - Sayı: 3, 227–230. https://ajindex.com/articles/551683

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Zuluaga MT. Chylothorax after surgery for congenital heart disease. Curr Opin Pediatr 2012;24:291–4
  2. McCulloch MA, Conaway MR, Haizlip JA, Buck ML, Bovbjerg VE, Hoke TR. Postoperative chylothorax development is associated with increased incidence and risk profile for central venous thromboses. Pediatr Cardiol 2008;29:556–61
  3. Chan EH, Russell JL, Williams WG, Van Arsdell GS, Coles JG, McCrindle BW. Postoperative chylothorax after cardiothoracic surgery in children. Ann Thorac Surg 2005;80:1864–70
  4. Biewer ES, Zürn C, Arnold R, Glöckler M, Schulte-Mönting J, Schlensak C, et al. Chylothorax after surgery on congenital heart disease in newborns and infants -risk factors and efficacy of MCT-diet. J Cardiothorac Surg 2010;5:127
  5. Cormack BE, Wilson NJ, Finucane K, West TM. Use of Monogen for pediatric postoperative chylothorax. Ann Thorac Surg 2004;77:301–5
  6. Paramés F, Freitas I, Fragata J, Trigo C, Pinto MF. Octreotide- -additional conservative therapy for postoperative chylothorax in congenital heart disease. Rev Port Cardiol 2009;28:799–807
  7. Migliori C, Boroni G, Milianti S, Ekema G. Chylothorax. [Article in Italian] Minerva Pediatr 2010;62(3 Suppl 1):89–91. [Abstract] 8. Das A, Shah PS. Octreotide for the treatment of chylothorax in neonates. Cochrane Database Syst Rev 2010;9:CD006388
  8. Panthongviriyakul C, Bines JE. Post-operative chylothorax in children: an evidence-based management algorithm. J Paediatr Child Health 2008;44:716–21
  9. Au M, Weber TR, Fleming RE. Successful use of somatostatin in a case of neonatal chylothorax. J Pediatr Surg 2003;38:1106–7
  10. Rimensberger PC, Müller-Schenker B, Kalangos A, Beghetti M. Treatment of a persistent postoperative chylothorax with somatostatin. Ann Thorac Surg 1998;66:253–4
  11. Soto-Martinez M, Massie J. Chylothorax: diagnosis and management in children. Paediatr Respir Rev 2009;10:199–207
  12. Kalomenidis I. Octreotide and chylothorax. Curr Opin Pulm Med 2006;12:264–7
  13. Goto M, Kawamata K, Kitano M, Watanabe K, Chiba Y. Treatment of chylothorax in a premature infant using somatostatin. J Perinatol 2003;23:563–4
  14. Helin RD, Angeles ST, Bhat R. Octreotide therapy for chylothorax in infants and children: A brief review. Pediatr Crit Care Med 2006;7:576–9
  15. Moreira-Pinto J, Rocha P, Osório A, Bonet B, Carvalho F, Duarte C, et al. Octreotide in the treatment of neonatal postoperative chylothorax: report of three cases and literature review. Pediatr Surg Int 2011;27:805–9
  16. Tutor